Zhenhao Lin

Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19.

J. Teijaro, Wanhong Xu, Lisa Kerwin, 2024, i Medicina.

Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19.

J. Teijaro, Wanhong Xu, Lisa Kerwin, 2023, i Medicina.